AI Article Synopsis

  • The study investigated the protective effects of safflower flower extract (SFFE) against liver damage and fat accumulation in a rat model of type 2 diabetes mellitus (T2DM) induced by a high-fat diet.
  • SFFE treatment led to significant reductions in blood glucose, cholesterol, and triglyceride levels, improved liver health, and enhanced certain protective pathways in both control and T2DM rats, although it did not lower fasting insulin levels.
  • The effects of SFFE were linked to activation of the Nrf2 pathway and inhibition of pro-inflammatory markers, with brusatol blocking these benefits, highlighting its role in liver protection.

Article Abstract

This study aimed to examine the hepatic and anti-steatotic protective effects of methanolic extract from (safflower) flowers (SFFE), using a rat model of type 2 diabetes mellitus (T2DM), and to examine the molecular mechanisms underlying these effects. Adult male Wistar rats were used for this study. First, T2DM was induced in some rats by feeding them a high-fat diet (HFD) for 4 weeks, followed by a single dose of streptozotocin (STZ) (35 mg/kg, i.p.). Experimental groups included the following five groups (n = 8 in each): control, control + SFFE, T2DM, T2DM + SFFE, and T2DM + SFFE + brusatol (an Nrf2 inhibitor, 2 mg/kg, i.p.). SFFE was administered at a concentration of 300 mg/kg, and all experiments concluded after 8 weeks. Treatments with SFFE significantly reduced fasting blood glucose levels, free fatty acids (FFAs), cholesterol, triglycerides, and low-density lipoprotein cholesterol in both the control and T2DM rats, but they failed to reduce fasting insulin levels in these groups. SFFE treatments also improved the liver structure and reduced hepatocyte vacuolization and hepatic levels of triglycerides and cholesterol in T2DM rats, in addition to increasing the hepatic mRNA levels of keap1 and the cytoplasmic levels and nuclear activities of Nrf2 in both the control and T2DM rats. SFFE also stimulated the expression levels of PPARα and CPT-1 but reduced the malondialdehyde (MDA), mRNA levels of SREBP1, fatty acid synthase, and acetyl CoA carboxylase in both the control and T2DM rats; meanwhile, it reduced hepatic mRNA and the nuclear activities of NF-κB and increased levels of glutathione, superoxide dismutase, and heme oxygenase-1 in the livers of both groups of treated rats. Furthermore, SFFE suppressed the levels of caspase-3, Bax, tumor necrosis factor-α, and interleukin-6 in the T2DM rats. Treatment with brusatol prevented all of these effects of SFFE. In conclusion, SFFE suppresses liver damage and hepatic steatosis in T2DM through Nrf2-dependent hypoglycemic, antioxidant, anti-inflammatory, and hypolipidemic effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428842PMC
http://dx.doi.org/10.3390/antiox13091098DOI Listing

Publication Analysis

Top Keywords

t2dm rats
20
control t2dm
12
sffe
11
t2dm
11
levels
9
rat model
8
model type
8
type diabetes
8
diabetes mellitus
8
nrf2-dependent hypoglycemic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!